LPCN vs UNP · rev $309.5K vs P/E 21, rev $6.86B
Lipocine Inc (LPCN) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
LPCN currently screens at market cap $19.3M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the LPCN and UNP stock pages for the full models.
Not investment advice.